[Elsevier] LANCET - Efficacy and safety of once-weekly semaglutide 2﹞4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial

Waltersport Post time 13 min. ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-13 20:03
Reward30points

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    8710


Return to the list